Dreyfus/The Boston Co Sm/Md Cp Gr Y (DBMYX)
* As of 28-Feb-14
Quotes delayed, except where indicated otherwise. Currency in USD.
- No Headlines available for DBMYX at this time.
|Morningstar Overall Rating:|
|Annual Report Expense Ratio (net):||0.72%|
Performance & Risk
|5y Avg Return:||25.44%|
|Rank in Category (ytd):||72|
|% Rank in Category (ytd):||9.47%|
|Morningstar Risk Rating:||2|
The investment seeks long-term growth of capital.
The fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of small-cap and mid-cap U.S. companies. The adviser currently considers small-cap and mid-cap companies to be those with total market capitalizations that are equal to or less than the total market capitalization of the largest company included in the Russell 2500Â® Growth Index, the fund's benchmark index. The fund is non-diversified. View More